Authors

  • Давлатова Г.Н., Садикова Ш.Э., Бердиева Ш.О.

Keywords:

талассемия, молекулярная диагностика.

References

Ahmed S, Saleem M, Modell B, Petrou M. 2018. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 347: 1162–1168.

Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. 1995. Prevention and control of haemoglobinopathies. Bull World Health Organ 73: 375–386.

Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, Francina A, Simeoni MC, Loundou A, Pissard S. 2021. Variants in genetic modifiers of β–thalassemia can help to predict the major or intermedia type of the disease. Haematologica 96: 1712–1714.

Canatan D, Kose MR, Ustundag M, Haznedaroglu D, Ozbas S. 2016. Hemoglobinopathy control program in Turkey. Community Genet 9: 124–126.

Chern JP, Lin KH, Su YN, Lu MY, Jou ST, Lin DT, Wang SC, Lin KS. 2016. Impact of a national β–thalassemia carrier screening program on the birth rate of thalassemia major. Pediatr Blood Cancer 46: 72–76.

Chui DH. 2015. a–Thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann NY Acad Sci 1054: 25–32.

Faa V, Masala M, Cao A, Rosatelli MC. 2020. a Globin gene duplications in β thalassemia patients with intact β globin gene. Blood Cells Mol Dis 44: 156–158.

Fucharoen G, Sanchaisuriya K, Saeung N, Dangwibul S, Fucharoen S. 2014. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south–east Asia. Bull World Health Organ 82: 364–372.

Galanello R, Sanna S, Perseu L, Sollaino MC, Satta S, Lai ME, Barella S, Uda M, Usala G, Abecasis GR, et al. 2009. Amelioration of Sardinian b0 thalassemia by genetic modifiers. Blood 114: 3935–3937.

Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. 2010. Fine–mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 42: 1049–1051.

Gibson WT, Harvard C, Qiao Y, Somerville MJ, Lewis ME, Rajcan–Separovic E. 2008. Phenotype–genotype characterization of a–thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3. Am J Med Genet A 146A: 225–232.

Modell B, Darlison M. 2008. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86: 480–487.